Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons.
The inhibitor of apoptosis (IAP) family of antiapoptotic genes, originally discovered in baculovirus, exists in animals ranging from insects to humans. Here, we investigated the ability of IAPs to suppress cell death in both a neuronal model of apoptosis and excitotoxicity. Cerebellar granule neurons undergo apoptosis when switched from 25 to 5 mM potassium, and excitotoxic cell death in response to glutamate. We examined the endogenous expression of four members of the IAP family, X chromosome-linked IAP (XIAP), rat IAP1 (RIAP1), RIAP2, and neuronal apoptosis inhibitory protein (NAIP), by semiquantitative reverse PCR and immunoblot analysis in cultured cerebellar granule neurons. Cerebellar granule neurons express significant levels of RIAP2 mRNA and protein, but expression of RIAP1, NAIP, and XIAP was not detected. RIAP2 mRNA content and protein levels did not change when cells were switched from 25 to 5 mM potassium. To determine whether ectopic expression of IAP influenced neuronal survival after potassium withdrawal or glutamate exposure, we used recombinant adenoviral vectors to target XIAP, human IAP1 (HIAP1), HIAP2, and NAIP into cerebellar granule neurons. We demonstrate that forced expression of IAPs efficiently blocked potassium withdrawal-induced N-acetyl-Asp-Glu-Val-Asp-specific caspase activity and reduced DNA fragmentation. However, neurons were only protected from apoptosis up to 24 h after potassium withdrawal, but not at later time points, suggesting that IAPs delay but do not block apoptosis in cerebellar granule neurons. In contrast, treatment with 100 microM or 1 mM glutamate did not induce caspase activity and adenoviral-mediated expression of IAPs had no influence on subsequent excitotoxic cell death.
Simons
M
M
Department of Neurology, University of Tübingen, Germany.
Beinroth
S
S
Gleichmann
M
M
Liston
P
P
Korneluk
R G
RG
MacKenzie
A E
AE
Bähr
M
M
Klockgether
T
T
Robertson
G S
GS
Weller
M
M
Schulz
J B
JB
D000256:Adenoviridae; D000257:Adenoviridae Infections; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology; D015853:Cysteine Proteinase Inhibitors / Q000235:genetics; D053938:DNA Fragmentation; D004789:Enzyme Activation / Q000502:physiology; D015967:Gene Expression Regulation, Viral; D018014:Gene Transfer Techniques; D020287:In Situ Nick-End Labeling; D051034:Inhibitor of Apoptosis Proteins; D009474:Neurons / Q000166:cytology* / Q000201:enzymology; D009498:Neurotoxins / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D014764:Viral Proteins / Q000235:genetics
D015853:Cysteine Proteinase Inhibitors; D051034:Inhibitor of Apoptosis Proteins; D009498:Neurotoxins; D012333:RNA, Messenger; D014764:Viral Proteins; C086430:inhibitor of apoptosis, Nucleopolyhedrovirus; C505407:CASP3 protein, human; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases